Menu

Impact Events

More
Date Lead Company Event Type Approval Change Approval Likelihood
8/10/26 Sionna Therapeutics (SION) SION‑719 for Cystic Fibrosis (CF) Subscribers Only Subscribers Only Subscribers Only
8/6/26 Agenus (AGEN) agenT-797 for Pneumococcal (Streptococcus pneumoniae) Vaccines Subscribers Only Subscribers Only Subscribers Only
8/6/26 Agenus (AGEN) agenT-797 for Acute Respiratory Failure, Acute Lung Injury (ALI), Acute Respiratory Distress Syndrome (ARDS) Subscribers Only Subscribers Only Subscribers Only
8/4/26 Otsuka Holdings (4578) Voyxact for Immunoglobulin A (IgA) Nephropathy (Berger's Disease) Subscribers Only Subscribers Only Subscribers Only
8/3/26 Rocket (RCKT) RP-A501 for Danon Disease Subscribers Only Subscribers Only Subscribers Only

Upcoming Catalysts

More
Expected Date Range Lead Company Drug Expected Catalyst
06/25/2025 Subscribers Only Subscribers Only Company - Analyst/R&D Update
06/25/2025 Subscribers Only Subscribers Only Company - Analyst/R&D Update
06/26/2025 Subscribers Only Subscribers Only Company - Analyst/R&D Update
09/08/2025 Subscribers Only Subscribers Only Company - Analyst/R&D Update
09/17/2025 Subscribers Only Subscribers Only Company - Analyst/R&D Update